Calcirol

Quick links to important sections

Calcirol

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calcirol

Property Description
Active ingredient Colecalciferol (Vitamin D3)
Primary Form Oral solution, Nano suspension, Soft gelatin capsules
Pharmacological Class Nutritional supplement, Vitamin D analogue, Anti-rachitic agent
General Purpose Correction of Vitamin D3 deficiency states
Origin/Type Derived substance (fat-soluble prohormone)

What Type of Medicine is Calcirol?

The proprietary medicine Calcirol is defined by its active pharmaceutical ingredient, Colecalciferol (also known as Cholecalciferol or Vitamin D3), and is classified as a nutritional supplement and an anti-rachitic agent. This compound is a fat-soluble vitamin that functions as a prohormone, meaning it is a precursor the body converts into a biologically active form. Colecalciferol is the type of vitamin D naturally synthesized in human skin following sun exposure, and it is the form clinically recognized for its high bioavailability when compared to the plant-derived Ergocalciferol (Vitamin D2). Vitamin D3 is essential for human health and effective mineral regulation.


What Forms of Colecalciferol are Available?

Colecalciferol is primarily provided in forms intended for oral administration, such as soft gelatin capsules, oral solutions, and specific nano suspensions. These diverse dosage forms are necessitated by the compound's fat-soluble nature, requiring the active ingredient to be dispersed in an oil base (for capsules) or an advanced aqueous base (for nano suspensions) to optimize its absorption. Additionally, the medicine is available in an injection form for specialized intramuscular delivery when oral intake is insufficient or impractical.


What is the General Purpose of Calcirol?

The general purpose of Calcirol is to address and prevent a deficiency state of Vitamin D3, which is critical for mineral homeostasis. The core mechanism involves enhancing the body's ability to absorb calcium and phosphate from the gastrointestinal tract. This action is paramount because the continuous supply of these minerals is required to support bone mineralization and maintain skeletal integrity, confirming its established role in foundational bone health. Colecalciferol is utilized for the treatment and prevention of deficiency states.

Regulatory References

  1. NIH: Vitamin D

What side effects are possible with Calcirol?

Possible Side Effects and Safety Information

The officially documented safety profile for Calcirol (Colecalciferol) centers primarily on the risk of elevated calcium levels, resulting from the vitamin’s action in enhancing calcium absorption. The primary risks are related to overexposure or pre-existing sensitivities, which can lead to excessive concentrations of calcium in the body.


Official Adverse Reactions by Frequency

Adverse reactions are classified in regulatory documents according to how often they occur:

  • Uncommon: Adverse effects related to elevated calcium levels, specifically Hypercalcemia (high calcium in the blood) and Hypercalciuria (high calcium excretion in the urine).
  • Rare: Effects documented in the gastrointestinal and nervous systems, including nausea, vomiting, constipation, abdominal pain, and headache.

System Classes and Serious Reactions

Adverse effects are grouped into System-Organ Classes. Gastrointestinal disorders and Metabolism and Nutrition disorders are commonly listed. The most serious adverse reaction associated with sustained, excessive exposure is Nephrocalcinosis, which involves the calcification of kidney tissue.

Safety Constraints and Monitoring

Regulatory safety information notes specific limitations for use. Colecalciferol is formally contraindicated in individuals with pre-existing conditions such as Hypercalcemia, Hypercalciuria, and calcium-containing Nephrolithiasis (kidney stones). Additionally, official labels specify that patients with renal impairment or those receiving high doses require careful monitoring of serum calcium and phosphate levels to mitigate the risk of adverse effects.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Colecalciferol (Calcirol), known as Hypervitaminosis D, is officially documented to result primarily in severe hypercalcemia (elevated blood calcium). This condition is typically associated with the intake of excessive or prolonged high doses and is not linked to sun exposure.

Documented Overdose Manifestations

Official regulatory sources describe a cluster of symptoms associated with toxicity:

  • Gastrointestinal and Systemic: Nausea, vomiting, loss of appetite, constipation, muscle weakness, and fatigue.
  • Fluid Imbalance: Excessive thirst (polydipsia) and increased urination (polyuria).
  • Neurological: Confusion, headache, and lethargy.

Severe Outcomes and Emergency Actions

Regulatory documents classify overdose as potentially severe or life-threatening due to the risk of irreversible renal damage (kidney failure) from nephrocalcinosis, and the potential for serious cardiac arrhythmias. Overdose risk is heightened in patients with severe renal impairment.

There is no specific antidote known for Colecalciferol toxicity. Management is symptomatic and supportive.

When Immediate Medical Help Is Required

Official labeling mandates that users seek immediate medical attention or contact emergency services if severe symptoms are present, such as profound confusion, signs of severe dehydration, vomiting, or suspected changes in heart rhythm. Immediate discontinuation of Calcirol and any calcium supplements is the mandatory first step in response to suspected overdose.

Therapeutic Uses of Calcirol

What Calcirol Treats: Main Uses and Benefits

Calcirol (cholecalciferol, or Vitamin D₃) is a form of supportive care applied across domains where additional symptomatic support is needed, primarily focusing on skeletal health and correcting underlying deficiencies.

Its main use is to help manage the prevention and treatment of Vitamin D deficiency, a condition characterized by periods of heightened symptoms. The medication is considered relevant for managing conditions that involve inadequate levels of Vitamin D.

Calcirol is commonly used to address symptom clusters that may become intense or disruptive, such as muscle weakness and generalized body aches. It is also applied in managing bone disorders like osteoporosis, osteomalacia, and rickets. Furthermore, it is relevant for supportive care in patients with specific conditions, such as chronic kidney disease or malabsorption syndromes, where the body's ability to utilize the vitamin is compromised. By providing this support, the treatment contributes to easing the overall symptom load and supports general well-being during symptomatic phases.


Quick Fact: Relief for Bone Health

Calcirol may assist with reducing the risk of fractures and supporting bone integrity, which are key concerns in conditions presenting with significant symptomatic burden.

Regulatory References

  1. Vitamin D - MedlinePlus

Eligibility and Restrictions for Use

The eligibility for Calcirol (Colecalciferol) is strictly defined by regulatory authorities and centers on a patient’s existing calcium status and organ function.

Populations for whom use is Contraindicated

The medicine is contraindicated in any patient diagnosed with Hypercalcemia (high blood calcium), Hypervitaminosis D (excessive Vitamin D levels), Hypersensitivity to the ingredient, or severe renal impairment. These absolute exclusions form the primary limit on use. Use is also restricted in cases of Nephrolithiasis (kidney stones) if chronic hypercalcemia is present.

Populations Requiring Restricted or Conditional Use

Use of high-dose formulations is not recommended for pregnant women, nursing mothers, or children under 18 years of age; only low, supplemental doses are typically permissible in these groups. Use in children under 12 years must be determined by a physician. Special caution and medical supervision are required for patients with comorbidities such as malabsorption syndromes, cardiac function impairment, or diseases like Sarcoidosis that affect calcitriol production. Geriatric patients require cautious dose selection due to potential attenuation of absorption.

What should I know about interactions with other medicines?

The official interaction profile for Colecalciferol (Calcirol) is primarily defined by documented effects on mineral regulation and changes to its systemic exposure, as specified in regulatory labeling. The regulatory profile is structured around pharmacodynamic and pharmacokinetic constraints.

Interactions Affecting Mineral Homeostasis

Co-administration with other Vitamin D Analogues (such as Calcitriol) is restricted by regulatory bodies due to the risk of additive toxicity, potentially leading to hypervitaminosis D and severe hypercalcaemia. A similar pharmacodynamic constraint exists when combining Colecalciferol with Thiazide Diuretics or high-dose Calcium-containing Preparations, as these combinations carry an officially described increased risk of developing hypercalcaemia. If hypercalcaemia occurs, it may potentiate the effects of Cardiac Glycosides (like Digoxin), increasing the risk of cardiac arrhythmias. Specific cautions are also noted for patients with Chronic Renal Failure, where the combination with Magnesium-containing Antacids increases the risk of hypermagnesaemia due to impaired clearance.

Exposure-Modifying Substances and Timing Rules

Regulatory labeling identifies pharmacokinetic interactions that alter Colecalciferol exposure. Certain Anticonvulsants (e.g., Phenytoin, Carbamazepine) may accelerate the metabolism of Colecalciferol, resulting in a documented reduction in its plasma concentration. Conversely, agents that interfere with fat absorption, such as Bile Acid Sequestrants (e.g., Cholestyramine) and Mineral Oils, may also lead to a documented reduction in systemic exposure. For compounds such as Aluminum-containing Antacids, administration requires a mandatory timing separation—Colecalciferol must be taken at least two hours before or four hours after the antacid—to mitigate the potential for enhanced aluminum absorption. The absorption of Colecalciferol itself is enhanced when taken with a high-fat meal.

Mechanism of Action

The mechanism of Colecalciferol (Vitamin D3) is defined by its role as a prohormone that, once metabolically activated, functions as a primary regulator of mineral homeostasis. Its effect profile is built entirely upon its biological actions at the molecular and systemic levels.

Prohormone Activation and VDR Gene Targeting

The compound acts within the domain of genomic receptor targeting by first undergoing a two-step activation cascade: conversion in the liver and then in the kidney by specific enzymes (hydroxylases) to produce the active hormone, Calcitriol (1,25( OH)2 D3). Calcitriol then binds to the nuclear Vitamin D Receptor (VDR), forming a transcription factor that precisely modulates gene expression. This engagement initiates or suppresses signaling sequences that lead to downstream physiological effects; this genomic modulation process typically involves a time delay.


Multi-Organ Mineral Transport Regulation

The active Calcitriol exerts a coordinated, multi-organ effect primarily on calcium and phosphate balance. By upregulating specific mineral transport proteins in the intestine, it significantly enhances the body's uptake of dietary minerals. Concurrently, it engages mechanisms that influence feedback regulation by suppressing the synthesis of Parathyroid Hormone (PTH) and promoting the conservation of calcium in the kidneys. This ultimately establishes a regulated state within the targeted pathways, leading to the establishment of specific serum mineral concentrations (normocalcemia and normophosphatemia).

Dosage and Administration Information

How to Use Calcirol

The usage of Calcirol, which contains Colecalciferol (Vitamin D3), is determined by official dosing guidelines that separate therapy into two procedural phases: an initial treatment phase and a long-term maintenance phase. These protocols outline the route of administration, frequency, dose differentiation, and specific conditions for proper intake.


Official Administration Protocol

Feature Official Instruction
Route of Administration The standard and primary route for all widely available forms (capsules, tablets, solutions) is oral.
Dosage Regimens Treatment doses for deficiency typically range from 1,000 IU to 4,000 IU daily or a high-potency regimen of 50,000 IU once weekly for a limited duration. Maintenance doses generally range from 800 IU to 2,000 IU daily.
Timing with Food Administration requires the medicine to be taken with water, preferably alongside the main meal of the day, to facilitate the absorption of the fat-soluble compound.
Form Handling Soft capsules must be swallowed whole and not chewed, whereas oral solutions and drops can be mixed with food or liquids prior to intake.

Procedural Context

This structured usage ensures the medicine is delivered under conditions that maximize its absorption and differentiates between the therapeutic requirement to correct a deficiency and the supportive requirement to maintain adequate levels. For example, the high-dose weekly schedule is exclusively designated for the limited treatment phase. The medicine is not recommended for use in cases of severe renal impairment, where its metabolism is compromised.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Calcirol (Colecalciferol)

Evidence for use in Correcting Vitamin D Deficiency

Research has extensively examined Colecalciferol (Vitamin D3) for its role in the prevention and correction of low Vitamin D levels. The evidence for this use includes Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies included a wide range of individuals, such as healthy adults, children, and those considered at higher risk due to factors like limited sun exposure or certain malabsorption syndromes.

The trials monitored the effect of Colecalciferol on key biochemical markers, such as the serum levels of 25-hydroxyvitamin D [25(OH)D]. Studies report that treatment administration was associated with measurable patterns of change in this biomarker. Despite the volume of research, certain details remain uncertain, such as the variability in how different studies define the precise cut-off for deficiency versus insufficiency. Additionally, long-term effects are not fully established for outcomes beyond bone health.


Evidence for use in Bone Disorders (Rickets and Osteomalacia)

The research base for using Colecalciferol in specific bone diseases like Rickets and Osteomalacia is deeply rooted in historical clinical data and observational settings. The evidence was studied for its role in correcting these structural bone problems. Studies in this area explored clinical outcomes related to changes in physical discomfort (such as bone pain) and patterns measured on radiographic markers of bone structure.


Evidence for use in Osteoporosis and Fracture Prevention

The research addressing Osteoporosis and the prevention of fractures primarily consists of Large-scale Randomized Controlled Trials (RCTs) and extensive Meta-analyses. The main outcomes research examined were the rate of non-vertebral fractures and changes in Bone Mineral Density (BMD). The findings were mixed across many trials, which has led to ongoing scientific discussion. Some studies reported patterns where Colecalciferol was associated with a lower incidence of falls, but trials showed inconsistent patterns regarding the rate of fracture prevention.


What is Still Uncertain About Colecalciferol Research

One major area of uncertainty is the heterogeneity and inconsistency of findings in the fracture prevention trials. The evidence highlights that the subgroup findings are uncertain in some areas, and results apply only to the populations studied. Additionally, comparative evidence is lacking for many potential long-term outcomes.

Frequently Asked Questions (FAQ)

Common questions about Calcirol (FAQ)


Q: How quickly does Calcirol start working?

The mechanism of Calcirol (Colecalciferol) requires the compound to first be chemically activated by the body, which takes time. While the initial process of mineral regulation may begin within a day, official information indicates that achieving the intended increase in Vitamin D blood levels is often observed after approximately one month of regular administration.

Q: Is it safe to take Calcirol with blood pressure medicine?

Regulatory documents explicitly describe a documented risk of hypercalcaemia (high calcium levels) when Colecalciferol is combined with Thiazide Diuretics, a type of blood pressure medicine. The official interaction profile does not list other common types of blood pressure medicines as having a known direct interaction, and all combined therapies are generally reviewed by a healthcare provider.

Q: Can Calcirol cause high calcium levels?

Yes, official safety information confirms that high blood calcium, known as Hypercalcaemia, is listed as an uncommon adverse reaction. This occurs because the medicine’s primary role is to enhance calcium absorption. Excessive or prolonged high levels of calcium are officially described as being associated with risks, such as the calcification of kidney tissue (Nephrocalcinosis).

Q: Can Calcirol interact with thyroid medication?

Official regulatory documents do not list common thyroid hormone replacement medicines, such as levothyroxine, as having a known direct drug interaction with Colecalciferol. However, combined therapies involving these agents are generally managed by a healthcare provider, given the medicine's role in affecting mineral balance.

Q: Are there studies about Calcirol's use in bone health?

Yes, regulatory overviews confirm that Colecalciferol has a well-established research base in bone health. Evidence is described for use in structural problems like Rickets and Osteomalacia. Studies have also examined its use in Osteoporosis and fracture prevention, though official summaries describe the findings in large-scale fracture prevention trials as mixed or inconsistent.

Q: What is the difference between Calcirol and other vitamin D supplements?

The active ingredient in Calcirol is Colecalciferol (Vitamin D3), which is the form the body naturally synthesizes from sun exposure. Official sources recognize Vitamin D3 as being more effective than the plant-derived Ergocalciferol (Vitamin D2) at raising and maintaining the target blood levels, though some regulatory bodies still consider the two forms to be clinically equivalent.

Q: Is it necessary to take Calcirol with food, or can it be taken on an empty stomach?

Official product information notes that administration is enhanced when taken with food. Since Colecalciferol is a fat-soluble substance, taking it with food, particularly a meal containing fat, is officially documented to significantly enhance its absorption into the body.

Q: What should I do if I accidentally take too much Calcirol?

Official regulatory information directs that, in the event of a suspected overdose, contact with a doctor or a poison control center is appropriate. Symptoms of overdose (Hypervitaminosis D) may officially include general weakness, fatigue, loss of appetite, and headache.

Q: How does Calcirol compare to natural sunlight exposure?

Natural sunlight is the body's primary way to produce its own Colecalciferol. Supplements are typically provided for individuals with officially determined inadequate sun exposure or deficiency. While sun exposure allows the body to self-regulate production, supplementation requires monitored administration to mitigate the officially described risk of toxicity (Hypervitaminosis D).

Q: Are there specific tests recommended before starting Calcirol?

Authoritative medical bodies commonly define deficiency based on a specific threshold of 25-hydroxyvitamin D in the blood. A blood test to establish baseline levels is a procedure commonly used by healthcare providers before deficiency treatment is initiated.

Q: Can Calcirol cause a skin rash or allergic reaction?

Official safety data lists Hypersensitivity reactions, such as severe swelling (angio-oedema), as possible, though the frequency is 'not known.' Less serious reactions, including a mild rash (urticaria or pruritus), are officially listed as rare adverse effects of the medicine.

Q: Why do some people feel no difference when taking Calcirol?

The medicine works slowly at the molecular level, taking time to activate and modulate genetic expression. Patient information notes that because of this time delay, a person may not feel any different when taking it, and it can take several weeks or months to reach the targeted level.

Q: Does Calcirol have an effect on mood or mental clarity?

Official adverse reaction lists include headache as a rare side effect, but they do not list effects on mood or mental clarity. While some research has examined the association between vitamin D status and cognition, changes in mood are not listed as an established, labeled drug effect.

Q: Is Calcirol safe for vegetarians or vegans?

Colecalciferol (Vitamin D3) is commonly sourced from lanolin (wool fat), which may be considered unacceptable by vegans. Additionally, the inactive ingredients in certain formulations, such as the gelatin used in capsules, may be animal-derived. The suitability depends entirely on the specific product formulation.

Q: Does Calcirol contain any common allergens?

Specific formulations of Colecalciferol may include inactive ingredients that are common allergens, such as peanut oil or soybean oil. The presence of any such substances will be detailed in the product's official regulatory labeling and ingredient list.

Q: Can children take Calcirol, and is there specific information available?

Yes, official labeling confirms the use of Colecalciferol in children. However, regulatory documents state that high-dose formulations are not recommended for individuals under 18 years old. Information concerning the use and appropriate administration for children under 12 years of age is determined by a healthcare provider.

Q: Is Calcirol safe for older adults or the elderly?

Official information indicates that Calcirol can be used in the geriatric population. However, it notes that cautious dose selection is generally considered for older adults due to the potential for age-related changes in organ function and reduced absorption.

Q: Can people with liver issues use Calcirol?

The compound’s activation process requires the liver for the first conversion step. Official disease interaction lists identify hepatobiliary dysfunction (liver/bile issues) as a potential concern. Patients with active liver conditions are generally managed with specific caution by a healthcare provider.

Q: Does Calcirol affect blood sugar levels?

Official adverse reaction lists do not mention blood sugar or glucose levels. However, some scientific studies have examined Colecalciferol’s role in metabolic pathways and have reported observed changes in glucose levels in specific patient groups, though this is not a formally listed drug effect.

Q: What happens if I miss a dose of Calcirol?

Patient instructions for a missed dose are provided in the regulatory labeling and should be referenced to ensure the integrity of the administration schedule.

Q: What is the expected duration of treatment with Calcirol?

Official dosing guidelines outline an initial treatment phase followed by a long-term maintenance phase. The initial phase to correct a deficiency typically lasts for a specified period, such as 6 to 12 weeks. This is then followed by a lower, ongoing administration to keep levels within the target range.

Q: Does Calcirol have any known interactions with herbal supplements?

Official regulatory warnings and patient guides state that a doctor or pharmacist should be consulted before taking any herbal products while on Colecalciferol. This is because the medicine's mechanism can be affected by substances that alter fat absorption or impact calcium regulation.

Q: Is it common to feel tired after starting Calcirol?

Tiredness (fatigue/lethargy) is not listed as a common or rare adverse reaction in regulatory documents. However, symptoms of Hypervitaminosis D (excessive levels) officially include weakness, fatigue, and lethargy. If unusual tiredness occurs, this is a key symptom to mention to a healthcare professional.

Q: Is Calcirol primarily used for adults?

Official documents outline indications and dosage regimens that are primarily established for adults for the treatment and prevention of Vitamin D deficiency states and related bone disorders. While a lower supplemental dose is permissible for children, the higher-dose treatment regimens are primarily studied and documented for the adult population.

Q: Are there common misunderstandings about what Calcirol is intended for?

Official patient information often clarifies that Calcirol is not merely a simple calcium supplement; rather, its role is to enhance the body's ability to absorb calcium and phosphate. Furthermore, it is a precursor (prohormone) that must be activated by the body, not the final active hormone itself.

How should Calcirol be stored and disposed of?

Calcirol (cholecalciferol) must be stored and disposed of according to mandatory regulatory instructions to ensure stability.

Storage

Mandatory Storage Conditions: Store at Controlled Room Temperature (typically 20 C–25 C). The product must be kept out of the reach of children and pets. It is mandatory to store the medicine in its original container and protect it from light, moisture, and freezing [1.6, 2.3, 3.7].

Disposal

Official Disposal Rules: Do not dispose of unused or expired medicine via wastewater or household trash [2.2, 3.5]. Patients are directed to dispose of the product through an official medicine take-back scheme or as advised by a healthcare professional or local waste authority [2.2, 3.2].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calcirol found in:

A-Z Index: